GR3034665T3 - Antitussive composition containing an antitussive and benzydamine - Google Patents
Antitussive composition containing an antitussive and benzydamineInfo
- Publication number
- GR3034665T3 GR3034665T3 GR20000402355T GR20000402355T GR3034665T3 GR 3034665 T3 GR3034665 T3 GR 3034665T3 GR 20000402355 T GR20000402355 T GR 20000402355T GR 20000402355 T GR20000402355 T GR 20000402355T GR 3034665 T3 GR3034665 T3 GR 3034665T3
- Authority
- GR
- Greece
- Prior art keywords
- antitussive
- pct
- benzydamine
- composition containing
- sec
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI940362A IT1274026B (it) | 1994-03-01 | 1994-03-01 | Composizione antitosse |
| PCT/EP1995/000658 WO1995023602A1 (en) | 1994-03-01 | 1995-02-22 | Antitussive composition containing an antitussive and benzydamine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3034665T3 true GR3034665T3 (en) | 2001-01-31 |
Family
ID=11368015
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR20000402355T GR3034665T3 (en) | 1994-03-01 | 2000-10-23 | Antitussive composition containing an antitussive and benzydamine |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US5932589A (el) |
| EP (1) | EP0748222B1 (el) |
| JP (1) | JP3348858B2 (el) |
| KR (1) | KR970701047A (el) |
| CN (1) | CN1088358C (el) |
| AT (1) | ATE195074T1 (el) |
| AU (1) | AU681257B2 (el) |
| BR (1) | BR9506956A (el) |
| CA (1) | CA2184594C (el) |
| CZ (1) | CZ284798B6 (el) |
| DE (1) | DE69518229T2 (el) |
| DK (1) | DK0748222T3 (el) |
| ES (1) | ES2149969T3 (el) |
| FI (1) | FI963394A0 (el) |
| GR (1) | GR3034665T3 (el) |
| HU (1) | HUT75937A (el) |
| IT (1) | IT1274026B (el) |
| NO (1) | NO309965B1 (el) |
| NZ (1) | NZ281230A (el) |
| PL (1) | PL178608B1 (el) |
| PT (1) | PT748222E (el) |
| RO (1) | RO117147B1 (el) |
| RU (1) | RU2143901C1 (el) |
| SK (1) | SK282567B6 (el) |
| UA (1) | UA37278C2 (el) |
| WO (1) | WO1995023602A1 (el) |
| ZA (1) | ZA951588B (el) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6124282A (en) * | 1997-05-22 | 2000-09-26 | Sellers; Edward M. | Drug formulations |
| EP2266564B1 (en) * | 1997-12-22 | 2013-03-13 | Euro-Celtique S.A. | Pharmaceutical oral dosage form comprising a combination of an opioid agonist and an opioid antagonist |
| US7138133B2 (en) | 2001-10-10 | 2006-11-21 | The Procter & Gamble Company | Orally administered liquid compositions |
| AU2003219348A1 (en) * | 2002-04-22 | 2003-11-03 | Adcock Ingram Intellectual Property (Proprietary) Limited | Pharmaceutical compositions comprising a decongenstant and further active ingredients for treating cough and flu |
| US9757461B2 (en) * | 2005-01-14 | 2017-09-12 | Camurus Ab | GnRH analogue formulations |
| WO2006075125A1 (en) * | 2005-01-14 | 2006-07-20 | Camurus Ab | GnRH ANALOGUE FORMULATIONS |
| CN101219140B (zh) * | 2007-12-24 | 2011-06-01 | 重庆市莱美药物技术有限公司 | 盐酸苄达明可溶片及其制备方法 |
| BR112012000410B8 (pt) | 2009-07-08 | 2020-12-08 | Acraf | uso de benzidamina ou dos sais de adição de ácido, e, composição farmacêutica |
| KR102290178B1 (ko) * | 2013-03-13 | 2021-08-18 | 트리스 파마 인코포레이티드 | 벤조나테이트 변형 방출 고체 정제 및 캡슐 |
| CN107873024A (zh) * | 2015-02-09 | 2018-04-03 | 塞尔利克斯生物私人有限公司 | 用于治疗粘膜炎的组合物和方法 |
| US11214544B2 (en) | 2017-04-14 | 2022-01-04 | Kempharm, Inc. | Dextrorphan prodrugs and processes for making and using them |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5196436A (en) * | 1990-10-31 | 1993-03-23 | The Procter & Gamble Company | Dextromethorphan antitussive compositions |
| SK42593A3 (en) * | 1990-10-31 | 1993-09-09 | Procter & Gamble | Antitusic agents |
-
1994
- 1994-03-01 IT ITMI940362A patent/IT1274026B/it active IP Right Grant
-
1995
- 1995-02-22 US US08/700,362 patent/US5932589A/en not_active Expired - Fee Related
- 1995-02-22 RO RO96-01736A patent/RO117147B1/ro unknown
- 1995-02-22 AT AT95909772T patent/ATE195074T1/de not_active IP Right Cessation
- 1995-02-22 RU RU96120415A patent/RU2143901C1/ru not_active IP Right Cessation
- 1995-02-22 CZ CZ962532A patent/CZ284798B6/cs not_active IP Right Cessation
- 1995-02-22 NZ NZ281230A patent/NZ281230A/en not_active IP Right Cessation
- 1995-02-22 ES ES95909772T patent/ES2149969T3/es not_active Expired - Lifetime
- 1995-02-22 CA CA002184594A patent/CA2184594C/en not_active Expired - Fee Related
- 1995-02-22 UA UA96093730A patent/UA37278C2/uk unknown
- 1995-02-22 PL PL95316079A patent/PL178608B1/pl not_active IP Right Cessation
- 1995-02-22 AU AU18116/95A patent/AU681257B2/en not_active Ceased
- 1995-02-22 PT PT95909772T patent/PT748222E/pt unknown
- 1995-02-22 EP EP95909772A patent/EP0748222B1/en not_active Expired - Lifetime
- 1995-02-22 CN CN95191917A patent/CN1088358C/zh not_active Expired - Fee Related
- 1995-02-22 HU HU9602390A patent/HUT75937A/hu unknown
- 1995-02-22 DE DE69518229T patent/DE69518229T2/de not_active Expired - Fee Related
- 1995-02-22 SK SK1085-96A patent/SK282567B6/sk unknown
- 1995-02-22 BR BR9506956A patent/BR9506956A/pt not_active IP Right Cessation
- 1995-02-22 KR KR1019960704800A patent/KR970701047A/ko not_active Application Discontinuation
- 1995-02-22 WO PCT/EP1995/000658 patent/WO1995023602A1/en active IP Right Grant
- 1995-02-22 DK DK95909772T patent/DK0748222T3/da active
- 1995-02-22 JP JP52267395A patent/JP3348858B2/ja not_active Expired - Fee Related
- 1995-02-24 ZA ZA951588A patent/ZA951588B/xx unknown
-
1996
- 1996-08-30 NO NO963634A patent/NO309965B1/no not_active IP Right Cessation
- 1996-08-30 FI FI963394A patent/FI963394A0/fi not_active Application Discontinuation
-
2000
- 2000-10-23 GR GR20000402355T patent/GR3034665T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EG22373A (en) | New pharmaceutical formulation | |
| AU1947895A (en) | Sublingual or buccal pharmaceutical composition | |
| PL327923A1 (en) | Novel combination of active ingredients containing clopidogrel and antithrombotic drug | |
| GR3034665T3 (en) | Antitussive composition containing an antitussive and benzydamine | |
| CA2279497A1 (en) | The use of levobupivacaine in facial surgery | |
| CA2152998A1 (en) | Anti-hyperglycemia pharmaceutical composition | |
| CA2313618A1 (en) | Transmucosal formulations of levosimendan | |
| HK1010344A1 (en) | Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade | |
| CA2077693A1 (en) | Use of ketorolac for treatment of periodontal disease | |
| BG106534A (en) | Oral solution containing galanthamine and a sweetening agent | |
| AU6519596A (en) | Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases | |
| CA2161683A1 (en) | Veterinary composition containing a proton pump inhibitor | |
| JO1821B1 (en) | New pharmaceutical product |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ML | Lapse due to non-payment of fees |